机译:HIV-1共识包络诱导宽染色抗体
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Department of Immunology Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Los Alamos National Laboratory Los Alamos New Mexico.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
Duke Human Vaccine Institute Duke University School of Medicine Durham North Carolina.;
antibody-mediated immunity; HIV; monoclonal; vaccine design; ADCC;
机译:HIV-1共识包络诱导宽染色抗体
机译:HIV-1感染的V2导向疫苗样抗体鉴定出具有广泛ADCC活性的其他K169结合轻链基序。
机译:宽度中和抗体与HIV-1的GP120糖蛋白之间相对结合自由能的自由能量扰动计算
机译:靶向靶向HIV-1包络CD4结合位点的宽度中和抗体的结构引导工程
机译:广泛中和抗体和广泛中和血清:对HIV-1疫苗设计的见解
机译:HIV-1共识信封诱导的广泛结合抗体。
机译:单个突变可将广泛中和抗体的非结合性生殖系样前身转变为针对HIV-1包膜糖蛋白的结合抗体